James Kanter
Directeur des opérations chez Flightpath Biosciences, Inc.
Postes actifs de James Kanter
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Flightpath Biosciences, Inc.
 Flightpath Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Flightpath Biosciences, Inc. operates as a biotechnology company. The firm develops novel therapeutics for the treatment of tick-borne diseases and acute and post treatment Lyme disease. The company was founded by Mark de Souza, Matthew Tindall, and Curtis Scribner in 2019 and is headquartered in Berkeley, CA. | Directeur des opérations | - | - |
Historique de carrière de James Kanter
Statistiques
Internationale
| Etats-Unis | 2 |
Opérationnelle
| Chief Operating Officer | 1 |
Sectorielle
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Flightpath Biosciences, Inc.
Flightpath Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Flightpath Biosciences, Inc. operates as a biotechnology company. The firm develops novel therapeutics for the treatment of tick-borne diseases and acute and post treatment Lyme disease. The company was founded by Mark de Souza, Matthew Tindall, and Curtis Scribner in 2019 and is headquartered in Berkeley, CA. | Health Technology |
- Bourse
- Insiders
- James Kanter
- Expérience
